Supporting health-related technology development at Kentucky's public universities and colleges

The KYNETIC (Kentucky Network for Innovation & Commercialization) program supports faculty, staff, trainees and students who want to accelerate introduction of their groundbreaking innovations to the marketplace to address unmet needs to benefit human health.


KYNETIC does this by:

  • Developing infrastructure for identifying technologies

  • Allocating funding (up to $200,000/technology) for product definition studies (e.g. feasibility studies, prototype development or proof-of-concept studies)

  • Providing access to early-stage development expertise and mentorship

  • Offering hands-on skills development in entrepreneurism

  • Accelerating development of commercialization strategies

Eligible KYNETIC technologies must originate from a participating university or community/technical college in Kentucky and focus on healthcare-related products. See the "application process" and "FAQs" sections below for more information on qualifying technologies.


The KYNETIC program is funded through the National Institute of Health’s (NIH) Research Evaluation and Commercialization Hub (REACH) program. The goal of the program is to support proof-of-concept centers (hubs) that facilitate and accelerate the translation of biomedical innovations into commercial products that improve patient care and enhance health.


The KYNETIC hub is led by the University of Kentucky (UK), University of Louisville (UofL) and Kentucky Commercialization Ventures (KCV).  The long-term goals of the program are to foster commercialization success, economic development and entrepreneurial culture change throughout Kentucky.

KYNETIC application process

KYNETIC is a competitive grant program, focused on product development to address unmet needs to benefit human health. Any member of the participating institutions in Kentucky is allowed to apply by submitting a short pre-application. Pre-applications will be reviewed as described below and the most promising will be invited to submit a full application.



Responsive pre-applications will be reviewed based on various criteria, including scientific merit, unmet need, human health benefit and relevance, intellectual property (IP) position, market potential, time to market and KYNETIC portfolio diversity.


Pre-application reviewers will include faculty with scientific, clinical, and/or entrepreneurship expertise, plus technology commercialization staff who will assess patentability and commercialization potential.


All applicants who submit a pre-application will be notified of the outcome (invited or not invited to present to the review panel) and will receive feedback on their application.


Pre-Application Materials

Email pre-application materials to



Those who submit a pre-application and are invited to formally apply will receive further instructions regarding preparation of the oral presentation.


Those who were not invited to formally apply will receive a brief description of why their pre-application was not selected and will be encouraged to meet with KYNETIC hub staff to discuss the possibility of resubmission.


Preparation of application and oral presentation will involve additional training in research commercialization and working with mentors to create a detailed product development plan.


While a research disclosure/invention report form is not required to submit a pre-application, completion of this form will be required prior to full proposal submission. Final funding decisions will be made following review by the KYNETIC External Review Board (ERB) and the NIH Technology Guidance Committee (TGC).

For any questions or to submit a pre-application, send an email to or

2020 Cycles

Request for applications: Jan. 1


Pre-proposal due: Feb. 15


Pre-proposal review: Mar. 1


Full proposal due: Apr. 15

Full proposal review: May 14


Start of project: Jul. 1

2020 Cycles

Request for applications: Jul. 1


Pre-proposal due: Aug. 14


Pre-proposal review: Sep. 1


Full proposal due: Oct. 15


Full proposal review: Nov. 1


Start of project: Jan. 1, 2021


Why is KYNETIC different from other grant programs?

The KYNETIC program is not a traditional grant program; it is product-focused, milestone driven and requires business-case project management. Applicants who are invited to submit a full application will work with KYNETIC staff and/or mentors to develop a product development plan and timeline with specified milestones.

What benchmarks will I have to meet in the program?

Receipt of funding for selected projects will be milestone-driven and KYNETIC staff will monitor development progress. There will be a continuation evaluation (go/no-go decision) every six months and non-progressing projects may be terminated and replaced with new projects.

Who is eligible for the KYNETIC program?

This RFA is open to all faculty, staff, trainees, and students at participating Kentucky state universities and community colleges. Non-faculty applicants must identify a faculty member who is willing to sponsor their application. Applications must focus on developing products that have the potential to improve patient care or enhance human health. All types of products (e.g. therapeutic, preventative, device, test, software) are eligible.

Does my institution participate the KYNETIC program?

The following institutions participate in the KYNETIC network: University of Kentucky, University of Louisville, Eastern Kentucky University, Kentucky State University, Morehead State University, Murray State University, Northern Kentucky University and Western Kentucky University. The network also includes the 16 colleges in the Kentucky Community and Technical College System.

Does my product have to treat one specific disease?

There is no disease-specific requirement, but it must be related to human health.

What's the policy on intellectual property?

Applications should involve ideas that originate from within a participating institution (making them potentially eligible for patent protection, copyright or some other mechanism) or university-derived technologies with pending/issued patents or copyright. Technologies that are already licensed to a company are not eligible.

What's the budget?

Requests for up to $50,000 per project, over a period of 6 months, will be considered. Projects are eligible for competitive renewal every 6 months, until a maximum of $200,000 per technology is reached.

KYNETIC presentation

Meet the KYNETIC team

Principal investigators

Linda Dwoskin, PhD
Principal Investigator
Department of Pharmaceutical Sciences
University of Kentucky
Expertise: Drug Development, Mechanistic Studies
Email Linda Dwoskin


Paula Bates, PhD
Principal Investigator
Department of Medicine
University of Louisville
Expertise: Drug Development, Mechanistic Studies
Email Paula Bates


Ian McClure, JD, LLM
Executive Director, Office of Technology Commercialization
University of Kentucky
Expertise: IP strategy, Technology Transfer, Entrepreneurship
Email Ian McClure


Allen Morris, PhD, MBA, CLP
Director, Commercialization EPI-Center
University of Louisville
Expertise: Technology Transfer, Strategy
Email Allen Morris

Other Key People

Jessica Sharon, MBA
Project Manager
Director of Innovation Programs
University of Louisville
Expertise: Bioengineering, Business
Email Jessica Sharon


Sarah Andres, PhD
Project Manager
James Graham Brown Cancer Center
University of Louisville
Expertise: Drug Development, Mechanistic Studies
Email Sarah Andres

Do you have an idea you’d like to share with us?

The Idea Disclosure Form is for use by faculty, staff, and students of KCV partner institutions. Megan Aanstoos is here to help with the commercialization process by taking ideas to product via the following steps:

For questions about the commercialization process and how KCV can help you, email or Megan Aanstoos, Licensing & New Ventures Manager at

At Work

Need more details? Contact us

© 2020 by Kentucky Science & Technology Corporation

Follow Us:

  • LinkedIn